Atlas Trials

He Huang

21 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch He Huang

RecordFirmDate
JY231(JY231) Injection for the Treatment of Refractory Autoimmune Diseases (ADs) (NCT06887985)He Huang2025-03-31
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Leukemia (NCT06902025)He Huang2025-03-31
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Lymphoma (NCT06879470)He Huang2025-03-01
CD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus Nephritis (NCT06785519)He Huang2025-01-31
A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/Refractory Acute Myeloid Leukemia (NCT06709131)He Huang2025-01-08
RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR (NCT06571825)He Huang2024-07-17
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research (NCT06120166)He Huang2023-11-16
A Study of the Safety and Preliminary Efficacy of LY-M001 Injection in the Treatment of Adult Patients With Gaucher Disease Type I (NCT06162338)He Huang2023-11-15
A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma (NCT06084962)He Huang2023-10-20
CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL (NCT05716113)He Huang2023-02-09
Human Leukocyte Antigen (HLA) Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation (NCT06809712)He Huang2022-08-04
Human Leukocyte Antigen (HLA) Mismatched Related Allogeneic Hematopoietic Stem Cell Transplantation (NCT06809699)He Huang2022-08-04
A Study of RD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma (NCT05444322)He Huang2022-07-05
Evaluate the Safety and Effect of ThisCART19A in Patients With AIDS Related B Cell Lymphoma/Lympholeukemia (NCT05340829)He Huang2022-03-18
A Study of CTA30X Cell Injection in Patients With Relapsed or Refractory CD19-positive B-line Hematological Malignancies (NCT04689204)He Huang2020-12-29
Clinical Study of Targeting CD19 and CD22 Chimeric Antigen Receptor T Lymphocytes in the Treatment of Recurrent or Refractory B Cell Non-Hodgkin Lymphoma (NCT04626908)He Huang2020-11-20
RD13-01 for Patients With r/r CD7+ T/NK Cell Hematologic Malignancies (NCT04538599)He Huang2020-09-10
Peripheral Blood Mononuclear Cell Collection Protocol for UCART Cell Tumor Immunotherapy Study (NCT04448509)He Huang2020-06-18
A Study of CT-RD06 Cell Injection in Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancy (NCT04226989)He Huang2020-02-05
A Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Malignancy (NCT04227015)He Huang2020-01-08
A Study of CD20/CD22 Targeted CAR T-cell Therapy for Relapsed or Refractory Lymphoid Malignancies (NCT04283006)He Huang2018-05-23

Track He Huang automatically

Every clearance here is in the API, with alerts when new ones post.